Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Riccardi, Rossano"'
Autor:
Di Valerio, Zeno, La Fauci, Giusy, Soldà, Giorgia, Montalti, Marco, Lenzi, Jacopo, Forcellini, Marcello, Barvas, Edoardo, Guttmann, Susanna, Poluzzi, Elisabetta, Raschi, Emanuel, Riccardi, Rossano, Fantini, Maria Pia, Salussolia, Aurelia, Gori, Davide
Publikováno v:
In eClinicalMedicine July 2022 49
Autor:
Montalti, Marco, Soldà, Giorgia, Di Valerio, Zeno, Salussolia, Aurelia, Lenzi, Jacopo, Forcellini, Marcello, Barvas, Edoardo, Guttmann, Susanna, Messina, Rossella, Poluzzi, Elisabetta, Raschi, Emanuel, Riccardi, Rossano, Fantini, Maria Pia, La Fauci, Giusy, Gori, Davide
Publikováno v:
In eClinicalMedicine August 2021 38
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giorgia Soldà, Edoardo Barvas, Jacopo Lenzi, Zeno Di Valerio, Giusy La Fauci, Susanna Guttmann, Rossano Riccardi, Maria Pia Fantini, Aurelia Salussolia, Marco Montalti, Davide Gori
Publikováno v:
Vaccines; Volume 10; Issue 3; Pages: 370
The Republic of San Marino COVID-19 vaccination campaign used Gam-COVID-Vac and Pfizer-BioNTech vaccines. To assess adverse events following immunization (AEFIs), approximately 6000 vaccine recipients were monitored by the ROCCA study, including subg
Autor:
Zeno Di Valerio, Giusy La Fauci, Giorgia Soldà, Marco Montalti, Jacopo Lenzi, Marcello Forcellini, Edoardo Barvas, Susanna Guttmann, Elisabetta Poluzzi, Emanuel Raschi, Rossano Riccardi, Maria Pia Fantini, Aurelia Salussolia, Davide Gori
Background: Gam-COVID-Vac is the world's first registered vector vaccine against COVID-19 based on a combination of two heterologous adenoviruses. It was chosen by the Republic of San Marino as the main tool in its vaccination campaign, which started
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cfd97f8af10d4efb0726be3ca9c911
http://hdl.handle.net/11585/887221
http://hdl.handle.net/11585/887221